Any feedback?
Literature summary for 3.5.1.88 extracted from
- Synthesis and in vitro antibacterial activity of (2S)-N-(substitutedphenyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxohexyl]-2-pyrrolidinecarboxamides as potential peptide deformylase inhibitors (2009), Chem. Biol. Drug Des., 73, 142-146.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | the gene encoding peptide deformylase is present in all sequenced pathogenic bacterial genomes, therefore peptide deformylase is an attractive target for antibacterial chemotherapy | Staphylococcus aureus |
| medicine | the gene encoding peptide deformylase is present in all sequenced pathogenic bacterial genomes, therefore peptide deformylase is an attractive target for antibacterial chemotherapy | Streptococcus pneumoniae |
| medicine | the gene encoding peptide deformylase is present in all sequenced pathogenic bacterial genomes, therefore peptide deformylase is an attractive target for antibacterial chemotherapy | Staphylococcus epidermidis |
| medicine | the gene encoding peptide deformylase is present in all sequenced pathogenic bacterial genomes, therefore peptide deformylase is an attractive target for antibacterial chemotherapy | Staphylococcus enteridis |
| medicine | the gene encoding peptide deformylase is present in all sequenced pathogenic bacterial genomes, therefore peptide deformylase is an attractive target for antibacterial chemotherapy | Staphylococcus non-hemolyticus |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | - |
Staphylococcus aureus |  |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | - |
Staphylococcus aureus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| BB-83698 | - |
Staphylococcus aureus | |
| BB-83698 | - |
Staphylococcus enteridis | |
| BB-83698 | - |
Staphylococcus epidermidis | |
| BB-83698 | - |
Staphylococcus non-hemolyticus | |
| BB-83698 | - |
Streptococcus pneumoniae | |
| LBM-415 | - |
Staphylococcus aureus | |
| LBM-415 | - |
Staphylococcus enteridis | |
| LBM-415 | - |
Staphylococcus epidermidis | |
| LBM-415 | - |
Staphylococcus non-hemolyticus | |
| LBM-415 | - |
Streptococcus pneumoniae | |
| N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
| N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus aureus | |
| N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus enteridis | |
| N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus epidermidis | |
| N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Staphylococcus non-hemolyticus | |
| N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | - |
Streptococcus pneumoniae | |
Metals/Ions
| Metals/Ions | Comment | Organism | Structure |
|---|---|---|---|
| Fe2+ | - |
Staphylococcus aureus | |
| Fe2+ | - |
Streptococcus pneumoniae | |
| Fe2+ | - |
Staphylococcus epidermidis | |
| Fe2+ | - |
Staphylococcus enteridis | |
| Fe2+ | - |
Staphylococcus non-hemolyticus | |
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | Staphylococcus aureus | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | ? | - |
? | |
| additional information | Streptococcus pneumoniae | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | ? | - |
? | |
| additional information | Staphylococcus epidermidis | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | ? | - |
? | |
| additional information | Staphylococcus enteridis | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | ? | - |
? | |
| additional information | Staphylococcus non-hemolyticus | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | ? | - |
? | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Staphylococcus aureus | - |
- |
- |
| Staphylococcus enteridis | - |
- |
- |
| Staphylococcus epidermidis | - |
- |
- |
| Staphylococcus non-hemolyticus | - |
- |
- |
| Streptococcus pneumoniae | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | Staphylococcus aureus | ? | - |
? | |
| additional information | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | Streptococcus pneumoniae | ? | - |
? | |
| additional information | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | Staphylococcus epidermidis | ? | - |
? | |
| additional information | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | Staphylococcus enteridis | ? | - |
? | |
| additional information | peptide deformylase is responsible for the removal of the N-formyl group from the terminal methionine residue in bacterial protein synthesis | Staphylococcus non-hemolyticus | ? | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| peptide deformylase | - |
Staphylococcus aureus |
| peptide deformylase | - |
Streptococcus pneumoniae |
| peptide deformylase | - |
Staphylococcus epidermidis |
| peptide deformylase | - |
Staphylococcus enteridis |
| peptide deformylase | - |
Staphylococcus non-hemolyticus |
IC50 Value
| IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Streptococcus pneumoniae | N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.049 microg/ml | Staphylococcus enteridis | N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.098 microg/ml | Streptococcus pneumoniae | N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Streptococcus pneumoniae | LBM-415 | |
| additional information | - |
0.195 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Streptococcus pneumoniae | N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Streptococcus pneumoniae | N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus enteridis | N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus aureus | N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus aureus | N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus enteridis | N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus non-hemolyticus | N-(3-chloro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus enteridis | N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Staphylococcus epidermidis | N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.195 microg/ml | Streptococcus pneumoniae | N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | LBM-415 | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | LBM-415 | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(1H-pyrrol-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus enteridis | N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus enteridis | N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Streptococcus pneumoniae | N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus aureus | N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus non-hemolyticus | N-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Streptococcus pneumoniae | N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Streptococcus pneumoniae | N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.39 microg/ml | Staphylococcus epidermidis | N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus non-hemolyticus | LBM-415 | |
| additional information | - |
0.78 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Streptococcus pneumoniae | N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus aureus | N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus epidermidis | N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
0.78 microg/ml | Staphylococcus epidermidis | N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus non-hemolyticus | N-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus epidermidis | N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus non-hemolyticus | N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus epidermidis | N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus aureus | N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
1.56 microg/ml | Staphylococcus enteridis | N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus enteridis | LBM-415 | |
| additional information | - |
3.13 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(3-methylphenyl)-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methylphenyl)-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-morpholin-4-ylphenyl)-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-piperidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-pyrrolidin-1-ylphenyl)-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Streptococcus pneumoniae | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | N-(3-chloro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus enteridis | N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | N-(3-fluoro-4-piperidin-1-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | N-(4-chlorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus aureus | N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus epidermidis | N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | N-[3-chloro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus aureus | N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | N-[3-fluoro-4-(1-oxidopiperidin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus aureus | N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus non-hemolyticus | N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus aureus | N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
3.13 microg/ml | Staphylococcus enteridis | N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
6.25 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | |
| additional information | - |
6.25 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(4-methoxyphenyl)-L-prolinamide | |
| additional information | - |
6.25 microg/ml | Staphylococcus non-hemolyticus | N-(3,4-difluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
6.25 microg/ml | Staphylococcus non-hemolyticus | N-[4-(4-ethylpiperazin-1-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-(2-methylphenyl)-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus aureus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus epidermidis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus enteridis | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus non-hemolyticus | 1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-N-[4-(4-oxidomorpholin-4-yl)phenyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus non-hemolyticus | N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus non-hemolyticus | N-(3-fluoro-4-morpholin-4-ylphenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus non-hemolyticus | N-(4-fluorophenyl)-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
| additional information | - |
larger than 6.25 microg/ml | Staphylococcus non-hemolyticus | N-[3-fluoro-4-(4-oxidomorpholin-4-yl)phenyl]-1-[(2R)-2-[[formyl(hydroxy)amino]methyl]hexanoyl]-L-prolinamide | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
